HCA Healthcare, Inc. $HCA Shares Purchased by Markel Group Inc.

Markel Group Inc. grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 11.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 68,963 shares of the company’s stock after acquiring an additional 6,962 shares during the period. Markel Group Inc.’s holdings in HCA Healthcare were worth $26,420,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Park Place Capital Corp lifted its position in shares of HCA Healthcare by 2,336.0% during the 2nd quarter. Park Place Capital Corp now owns 1,218 shares of the company’s stock valued at $474,000 after acquiring an additional 1,168 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of HCA Healthcare by 11.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,454 shares of the company’s stock worth $8,796,000 after purchasing an additional 2,698 shares in the last quarter. Harrell Investment Partners LLC increased its stake in shares of HCA Healthcare by 176.3% during the 2nd quarter. Harrell Investment Partners LLC now owns 1,815 shares of the company’s stock worth $695,000 after purchasing an additional 1,158 shares in the last quarter. Brown Advisory Inc. increased its stake in shares of HCA Healthcare by 53.9% during the 1st quarter. Brown Advisory Inc. now owns 4,630 shares of the company’s stock worth $1,600,000 after purchasing an additional 1,622 shares in the last quarter. Finally, Simplicity Wealth LLC increased its stake in shares of HCA Healthcare by 92.7% during the 2nd quarter. Simplicity Wealth LLC now owns 1,798 shares of the company’s stock worth $689,000 after purchasing an additional 865 shares in the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

HCA Healthcare Stock Down 0.3%

Shares of NYSE HCA opened at $466.34 on Wednesday. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $469.18. The firm has a fifty day moving average of $417.60 and a 200-day moving average of $384.15. The stock has a market capitalization of $109.12 billion, a PE ratio of 18.03, a P/E/G ratio of 1.43 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The company had revenue of $19.16 billion during the quarter, compared to analysts’ expectations of $18.55 billion. During the same period in the previous year, the company earned $4.90 EPS. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, December 29th. Investors of record on Monday, December 15th will be issued a dividend of $0.72 per share. The ex-dividend date is Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is presently 11.13%.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on HCA. Morgan Stanley set a $425.00 price objective on shares of HCA Healthcare in a research note on Monday. JPMorgan Chase & Co. raised their price objective on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a “neutral” rating in a research note on Monday, August 4th. Truist Financial lifted their target price on shares of HCA Healthcare from $460.00 to $495.00 and gave the stock a “buy” rating in a research note on Monday. Barclays lifted their target price on shares of HCA Healthcare from $445.00 to $494.00 and gave the stock an “overweight” rating in a research note on Monday. Finally, TD Cowen lifted their target price on shares of HCA Healthcare from $380.00 to $490.00 and gave the stock a “buy” rating in a research note on Monday. Fourteen investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $473.53.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction on Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the transaction, the executive vice president owned 31,503 shares in the company, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Insiders own 1.30% of the company’s stock.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.